149 related articles for article (PubMed ID: 28405520)
1. The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications.
Chen YP; Zhang J; Wang YQ; Liu N; He QM; Yang XJ; Sun Y; Ma J
Oncoimmunology; 2017; 6(3):e1288329. PubMed ID: 28405520
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
3. The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability.
Tang J; Jiang W; Liu D; Luo J; Wu X; Pan Z; Ding P; Li Y
Oncoimmunology; 2018; 7(10):e1488566. PubMed ID: 30288357
[TBL] [Abstract][Full Text] [Related]
4. Immune Landscape of the B7 and TNFR Families in Oral Squamous Cell Carcinoma.
Ren XY; Chen XJ; Chen XB; Wang CY; Liu Q; Pan X; Zhang SY; Zhang WL; Cheng B
Chin J Dent Res; 2020; 23(2):109-117. PubMed ID: 32548602
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.
Xu Z; Shen J; Wang MH; Yi T; Yu Y; Zhu Y; Chen B; Chen J; Li L; Li M; Zuo J; Jiang H; Zhou D; Luan J; Xiao Z
Oncoimmunology; 2016 Aug; 5(8):e1207841. PubMed ID: 27622076
[TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
7. High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression.
Bahr K; Zimmer S; Springer E; Fottner C; Becker S; Ernst BP; Matthias C; Künzel J
ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):309-316. PubMed ID: 31550725
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer.
Zhao Q; Hu F; Xiao Z; Li M; Wu X; Zhao Y; Wu Y; Yin J; Lin L; Zhang H; Zhang L; Cho CH; Shen J
Cell Prolif; 2018 Oct; 51(5):e12468. PubMed ID: 29999557
[TBL] [Abstract][Full Text] [Related]
9. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
[TBL] [Abstract][Full Text] [Related]
10. [Lymphocyte coreceptors].
Olive D
Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia.
Chen X; Liu S; Wang L; Zhang W; Ji Y; Ma X
Cancer Biol Ther; 2008 May; 7(5):622-7. PubMed ID: 18756622
[TBL] [Abstract][Full Text] [Related]
12. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Miyauchi S; Sanders PD; Guram K; Kim SS; Paolini F; Venuti A; Cohen EEW; Gutkind JS; Califano JA; Sharabi AB
Cancer Res; 2020 Feb; 80(4):732-746. PubMed ID: 31848196
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
14. PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.
Wang J; Yuan R; Song W; Sun J; Liu D; Li Z
J Hematol Oncol; 2017 Jan; 10(1):34. PubMed ID: 28122590
[TBL] [Abstract][Full Text] [Related]
15. The B7 family revisited.
Greenwald RJ; Freeman GJ; Sharpe AH
Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7-H1 in inflammatory renal tubular epithelial cells.
Chen Y; Zhang J; Li J; Zou L; Zhao T; Tang Y; Wu Y
Nephron Exp Nephrol; 2006; 102(3-4):e81-92. PubMed ID: 16282703
[TBL] [Abstract][Full Text] [Related]
18. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.
Straub M; Drecoll E; Pfarr N; Weichert W; Langer R; Hapfelmeier A; Götz C; Wolff KD; Kolk A; Specht K
Oncotarget; 2016 Mar; 7(11):12024-34. PubMed ID: 26918453
[TBL] [Abstract][Full Text] [Related]
19. Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells: B7-H1 induction by Porphyromonas gingivalis fractions.
Groeger S; Jarzina F; Mamat U; Meyle J
Immunobiology; 2017 Feb; 222(2):137-147. PubMed ID: 28164807
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]